ANPP Gains Voting Seat in US Pharmacopeia

The National Agency of Pharmaceutical Products (ANPP) has officially joined the United States Pharmacopeia (USP) as a voting member. This development, made public on November 9, represents a new step for Algeria in international pharmaceutical governance. The Pharmaceutical Industry Ministry stated this membership allows the agency to contribute to an international body of experts focused on developing pharmaceutical standards.

The United States Pharmacopeia is an independent, non-profit scientific organization responsible for establishing and publishing the American Pharmacopeia. This globally recognized compendium provides reference standards for the quality, safety, and compliance of medicines, dietary supplements, and raw materials. Algeria's ANPP, through its new voting rights, is now positioned to actively participate in the development and harmonization of these crucial international standards.

This move is part of Algeria's ongoing efforts to enhance its regulatory performance and safeguard public health. The ANPP's participation in the USP will facilitate the exchange of expertise and experiences with leading international bodies, reinforcing national capabilities in pharmaceutical evaluation, quality control, and regulatory harmonization. Ultimately, this collaboration aims to continuously improve the quality of pharmaceutical products, ensuring patient protection and strengthening Algeria's presence regionally and internationally.